JP2017007947A - 体温低下抑制剤 - Google Patents
体温低下抑制剤 Download PDFInfo
- Publication number
- JP2017007947A JP2017007947A JP2015121330A JP2015121330A JP2017007947A JP 2017007947 A JP2017007947 A JP 2017007947A JP 2015121330 A JP2015121330 A JP 2015121330A JP 2015121330 A JP2015121330 A JP 2015121330A JP 2017007947 A JP2017007947 A JP 2017007947A
- Authority
- JP
- Japan
- Prior art keywords
- body temperature
- decrease
- energy metabolism
- tua4337l
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036760 body temperature Effects 0.000 title claims abstract description 49
- 239000003112 inhibitor Substances 0.000 title claims abstract description 27
- 230000037149 energy metabolism Effects 0.000 claims abstract description 33
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 230000007423 decrease Effects 0.000 claims description 49
- 241000186660 Lactobacillus Species 0.000 claims description 8
- 229940039696 lactobacillus Drugs 0.000 claims description 8
- 239000000463 material Substances 0.000 abstract description 6
- 241000186684 Lactobacillus pentosus Species 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 235000009200 high fat diet Nutrition 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000012631 food intake Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000002631 hypothermal effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 238000001061 Dunnett's test Methods 0.000 description 2
- 206010016326 Feeling cold Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 230000007371 visceral function Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 238000013218 HFD mouse model Methods 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
【解決手段】ラクトバチルス・ペントーサス TUA4337L株(受託番号NITE BP-1479)の菌体またはその処理物を有効成分とする、エネルギー代謝の低下に伴う体温低下の抑制剤、ならびに、ラクトバチルス・ペントーサス TUA4337L株(受託番号NITE BP-1479)の菌体またはその処理物を有効成分とする、エネルギー代謝低下の抑制剤。
【選択図】なし
Description
〔1〕 ラクトバチルス・ペントーサス TUA4337L株(受託番号NITE BP-1479)の菌体又はその処理物を有効成分とする、エネルギー代謝の低下に伴う体温低下の抑制剤。
〔2〕 ラクトバチルス・ペントーサス TUA4337L株(受託番号NITE BP-1479)の菌体又はその処理物を有効成分とする、エネルギー代謝低下の抑制剤。
高脂肪食の摂取を続けることにより体重当りのエネルギー代謝が低下することが知られていることから、高脂肪食マウスを用いてTUA4337L株の菌体又はその処理物によるエネルギー代謝亢進作用を検討した。
消費カロリー:VO2×(RER×1.232+3.815)/1000
呼吸商(RER):VCO2/VO2
TUA4337L株の菌体又はその処理物による体温低下抑制作用の用量依存性を検討した。
Claims (2)
- ラクトバチルス・ペントーサス TUA4337L株(受託番号NITE BP-1479)の菌体又はその処理物を有効成分とする、エネルギー代謝の低下に伴う体温低下の抑制剤。
- ラクトバチルス・ペントーサス TUA4337L株(受託番号NITE BP-1479)の菌体又はその処理物を有効成分とする、エネルギー代謝低下の抑制剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015121330A JP6645756B2 (ja) | 2015-06-16 | 2015-06-16 | 体温低下抑制剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015121330A JP6645756B2 (ja) | 2015-06-16 | 2015-06-16 | 体温低下抑制剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017007947A true JP2017007947A (ja) | 2017-01-12 |
JP6645756B2 JP6645756B2 (ja) | 2020-02-14 |
Family
ID=57761288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015121330A Active JP6645756B2 (ja) | 2015-06-16 | 2015-06-16 | 体温低下抑制剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6645756B2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019083713A (ja) * | 2017-11-02 | 2019-06-06 | 大塚食品株式会社 | 身体の冷え改善用の飲食品組成物 |
JP2019218324A (ja) * | 2018-06-22 | 2019-12-26 | 花王株式会社 | 低体温改善剤 |
CN114410547A (zh) * | 2022-02-25 | 2022-04-29 | 西南大学 | 一株能促进5-htp分泌及缓解抑郁的戊糖乳杆菌lpq1及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014171478A1 (ja) * | 2013-04-17 | 2014-10-23 | サントリーホールディングス株式会社 | ラクトバチルス属菌含有組成物 |
-
2015
- 2015-06-16 JP JP2015121330A patent/JP6645756B2/ja active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014171478A1 (ja) * | 2013-04-17 | 2014-10-23 | サントリーホールディングス株式会社 | ラクトバチルス属菌含有組成物 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019083713A (ja) * | 2017-11-02 | 2019-06-06 | 大塚食品株式会社 | 身体の冷え改善用の飲食品組成物 |
JP7027126B2 (ja) | 2017-11-02 | 2022-03-01 | 大塚食品株式会社 | 身体の冷え改善用の飲食品組成物 |
JP2019218324A (ja) * | 2018-06-22 | 2019-12-26 | 花王株式会社 | 低体温改善剤 |
CN114410547A (zh) * | 2022-02-25 | 2022-04-29 | 西南大学 | 一株能促进5-htp分泌及缓解抑郁的戊糖乳杆菌lpq1及其应用 |
Also Published As
Publication number | Publication date |
---|---|
JP6645756B2 (ja) | 2020-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2008288581B2 (en) | Lactobacillus rhamnosus and weight control | |
CN105025909B (zh) | 应激减轻剂 | |
US11197901B2 (en) | Active substance of Lactobacillus paracasei GKS6, a composition comprising thereof and its use for promoting longevity | |
US8246946B2 (en) | Treatment of bipolar disorder utilizing anti-fungal compositions | |
CN106795482B (zh) | 允许在营养不良的情况下促进人和动物的幼年生长的乳杆菌组合物 | |
JP6596135B2 (ja) | 腸内環境改善、高脂肪食摂取による体重増加抑制またはピロリ菌抑制のための組成物 | |
US20220143114A1 (en) | Active substance of lactobacillus plantarum gkm3, a composition comprising thereof and its use for promoting longevity | |
JP6645756B2 (ja) | 体温低下抑制剤 | |
JP6214162B2 (ja) | 新規の低温耐性ラクトバチルス・ガセリ株 | |
US20130189236A1 (en) | Prevention And Treatment Of Gastrointestinal Infection In Mammals | |
US20200054692A1 (en) | Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same | |
KR101987321B1 (ko) | 장 및 뇌건강 개선 기능성 반려동물 사료첨가제 | |
KR20220149935A (ko) | 김치유래 유산균을 포함하는 프로바이오틱스 조성물 및 이의 용도 | |
CN110087656A (zh) | 肌苷在治疗T-reg缺乏中的应用 | |
JP5394628B2 (ja) | 新規なラクトバチルス属微生物および乳酸菌製剤 | |
KR102480131B1 (ko) | 인지능력 개선 기능을 가지는 락토바실러스 람노수스 | |
JP2010041940A (ja) | 新属シャーペア(Sharpea)属に属する微生物および微生物製剤並びに経口組成物 | |
JP2009100692A (ja) | 新規なラクトバチルス属微生物および哺乳動物用乳酸菌製剤 | |
JP2014101282A (ja) | ストレス性下痢の抑制剤 | |
Kaya et al. | In case of obesity, longevity-related mechanisms lead to anti-inflammation | |
JP2014101288A (ja) | ストレス性腸障害の抑制剤 | |
CN111212902B (zh) | 刺激生长的乳杆菌菌株 | |
Al-Faragi et al. | Effect of local probiotic on common carp Cyprinus carpio growth performance and survival rate | |
JP4823503B2 (ja) | Lactobacillusfermentumの新規微生物株GM−090、およびIFN−γ分泌の刺激および/またはアレルギーの処置のためのその使用。 | |
JP6785141B2 (ja) | 基礎代謝亢進剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20150617 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180510 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190417 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190513 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190711 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190829 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191219 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200109 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6645756 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |